Engineered vector evades photoreceptor pathology and microglia and CD8
Por um escritor misterioso
Descrição
Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment: Molecular Therapy - Methods & Clinical Development
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses
IJMS, Free Full-Text
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based Bioprinting
Issue: Molecular Therapy
US20200270637A1 - Compositions and methods for inhibiting viral vector-induced inflammatory responses - Google Patents
Tyler KRAUSE, Virology PhD Candidate, Harvard Medical School, MA, HMS, Department of Genetics
M SpringerLink
Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety - ScienceDirect
IJMS, Free Full-Text
WO2019094548A1 - Compositions and methods for inhibiting viral vector-induced inflammatory responses - Google Patents
CD11b Monoclonal Antibody (M1/70) (14-0112-82)
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
